TY - JOUR
T1 - Co-option of the lineage-specific LAVA retrotransposon in the gibbon genome
AU - Okhovat, Mariam
AU - Nevonen, Kimberly A.
AU - Davis, Brett A.
AU - Michener, Pryce
AU - Ward, Samantha
AU - Milhaven, Mark
AU - Harshman, Lana
AU - Sohota, Ajuni
AU - Fernandes, Jason D.
AU - Salama, Sofie R.
AU - O'Neill, Rachel J.
AU - Ahituv, Nadav
AU - Veeramah, Krishna R.
AU - Carbone, Lucia
N1 - Funding Information:
Angeles Zoo) and the staff at the Gibbon Conservation Center (Santa Clarita, CA), especially the director Gabriella Skollar, who have provided us with opportunistic gibbon blood samples. We also thank Dr. Jeff Wall and Dr. Michael Hammer for their invaluable contributions to WGS data collection; Dr. Eugene Gardner for aiding in optimizing the MELT pipeline; Dr. Jessica Minnier for guidance in RNA-seq analysis; Dr. R. Alan Harris, Patty Langasek, and Christopher Klocke for their help with data analysis; and members of the laboratory of Dr. Shawn Chavez and L.C. for valuable feedback on the research. We acknowledge the ENCODE Consortium and Dr. Myers at HudsonAlpha Institute for Biotechnology, who generated the human PU.1 ChIP-seq data. Gibbon PU.1 ChIP-seq was performed by the Epigenetics Consortium at Knight Cardiovascular Institute of Oregon Health and Science University (OHSU). All ChIP-seq libraries were sequenced at the OHSU Massively Parallel Sequencing Shared Resource and the Genomics and Cell Characterization Core Facility at the University of Oregon. Data analyses were performed on the Exacloud super computer cluster at OHSU. This work was financially supported by a grant awarded to L.C. from the Leakey Foundation. R.J.O. and L.C. are also supported by National Science Foundation (NSF) Grant 1613856, N.A. and L.C. are supported by National Human Genome Research Institute (NHGRI) Grant R01HG010333, and L.C. is supported by National Insitute of Health Office of Directors (NIH/OD) Grant P51 OD011092 (to the Oregon National Primate Research Center). J.D.F. is supported by National Institute of General Medical Sciences (NIGMS) Grant F32GM125388, and S.R.S. is funded by NHGRI Grant 1R01HG010329.
Funding Information:
We thank the zoos (San Antonio Zoo and Aquarium, Point Defiance Zoo and Aquarium, Oregon Zoo, Gladys Porter Zoo, and Los Angeles Zoo) and the staff at the Gibbon Conservation Center (Santa Clarita, CA), especially the director Gabriella Skollar, who have provided us with opportunistic gibbon blood samples. We also thank Dr. Jeff Wall and Dr. Michael Hammer for their invaluable contributions to WGS data collection; Dr. Eugene Gardner for aiding in optimizing the MELT pipeline; Dr. Jessica Minnier for guidance in RNA-seq analysis; Dr. R. Alan Harris, Patty Langasek, and Christopher Klocke for their help with data analysis; and members of the laboratory of Dr. Shawn Chavez and L.C. for valuable feedback on the research. We acknowledge the ENCODE Consortium and Dr. Myers at HudsonAlpha Institute for Biotechnology, who generated the human PU.1 ChIP-seq data. Gibbon PU.1 ChIP-seq was performed by the Epigenetics Consortium at Knight Cardiovascular Institute of Oregon Health and Science University (OHSU). All ChIP-seq libraries were sequenced at the OHSU Massively Parallel Sequencing Shared Resource and the Genomics and Cell Characterization Core Facility at the University of Oregon. Data analyses were performed on the Exacloud super computer cluster at OHSU. This work was financially supported by a grant awarded to L.C. from the Leakey Foundation. R.J.O. and L.C. are also supported by National Science Foundation (NSF) Grant 1613856, N.A. and L.C. are supported by National Human Genome Research Institute (NHGRI) Grant R01HG010333, and L.C. is supported by National Insitute of Health Office of Directors (NIH/OD) Grant P51 OD011092 (to the Oregon National Primate Research Center). J.D.F. is supported by National Institute of General Medical Sciences (NIGMS) Grant F32GM125388, and S.R.S. is funded by NHGRI Grant 1R01HG010329.
Publisher Copyright:
© 2020 National Academy of Sciences. All rights reserved.
PY - 2020/8/11
Y1 - 2020/8/11
N2 - Co-option of transposable elements (TEs) to become part of existing or new enhancers is an important mechanism for evolution of gene regulation. However, contributions of lineage-specific TE insertions to recent regulatory adaptations remain poorly understood. Gibbons present a suitable model to study these contributions as they have evolved a lineage-specific TE called LAVA (LINE-AluSz-VNTR-AluLIKE), which is still active in the gibbon genome. The LAVA retrotransposon is thought to have played a role in the emergence of the highly rearranged structure of the gibbon genome by disrupting transcription of cell cycle genes. In this study, we investigated whether LAVA may have also contributed to the evolution of gene regulation by adopting enhancer function. We characterized fixed and polymorphic LAVA insertions across multiple gibbons and found 96 LAVA elements overlapping enhancer chromatin states. Moreover, LAVA was enriched in multiple transcription factor binding motifs, was bound by an important transcription factor (PU.1), and was associated with higher levels of gene expression in cis. We found gibbon-specific signatures of purifying/positive selection at 27 LAVA insertions. Two of these insertions were fixed in the gibbon lineage and overlapped with enhancer chromatin states, representing putative co-opted LAVA enhancers. These putative enhancers were located within genes encoding SETD2 and RAD9A, two proteins that facilitate accurate repair of DNA double-strand breaks and prevent chromosomal rearrangement mutations. Co-option of LAVA in these genes may have influenced regulation of processes that preserve genome integrity. Our findings highlight the importance of considering lineage-specific TEs in studying evolution of gene regulatory elements.
AB - Co-option of transposable elements (TEs) to become part of existing or new enhancers is an important mechanism for evolution of gene regulation. However, contributions of lineage-specific TE insertions to recent regulatory adaptations remain poorly understood. Gibbons present a suitable model to study these contributions as they have evolved a lineage-specific TE called LAVA (LINE-AluSz-VNTR-AluLIKE), which is still active in the gibbon genome. The LAVA retrotransposon is thought to have played a role in the emergence of the highly rearranged structure of the gibbon genome by disrupting transcription of cell cycle genes. In this study, we investigated whether LAVA may have also contributed to the evolution of gene regulation by adopting enhancer function. We characterized fixed and polymorphic LAVA insertions across multiple gibbons and found 96 LAVA elements overlapping enhancer chromatin states. Moreover, LAVA was enriched in multiple transcription factor binding motifs, was bound by an important transcription factor (PU.1), and was associated with higher levels of gene expression in cis. We found gibbon-specific signatures of purifying/positive selection at 27 LAVA insertions. Two of these insertions were fixed in the gibbon lineage and overlapped with enhancer chromatin states, representing putative co-opted LAVA enhancers. These putative enhancers were located within genes encoding SETD2 and RAD9A, two proteins that facilitate accurate repair of DNA double-strand breaks and prevent chromosomal rearrangement mutations. Co-option of LAVA in these genes may have influenced regulation of processes that preserve genome integrity. Our findings highlight the importance of considering lineage-specific TEs in studying evolution of gene regulatory elements.
KW - Cis-regulatory element
KW - Co-option
KW - DNA repair
KW - Transcription factor binding
KW - Transposable element
UR - http://www.scopus.com/inward/record.url?scp=85089606761&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089606761&partnerID=8YFLogxK
U2 - 10.1073/pnas.2006038117
DO - 10.1073/pnas.2006038117
M3 - Article
C2 - 32690705
AN - SCOPUS:85089606761
SN - 0027-8424
VL - 117
SP - 19328
EP - 19338
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 32
ER -